Pharmaceutical firm Cipla Ltd has entered into an agreement with Biopharm SPA to form a joint venture company in Algeria to manufacture and market respiratory products, the company said today. In ...

Meda and Cipla will cooperate on product development of Dymista. Cipla will be responsible for formulation, while Meda will be responsible for clinical development, registration, marketing and sales.

Cell therapy products will give patients suffering from a series of diseases relief through advanced treatment. This marks the second joint venture between Cipla and Kemwell Biopharma, following ...